This announcement is a separate document:
西藏药业2024年半年度报告摘要
Summary of Tibet Rhodiola Pharmaceutical Holding's H1 2024 report.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated